Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07541365 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials
A NA study, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07541365 is a NA study that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 30 participants.
The verdict
NCT07541365, a NA study, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Wearable sensors offer opportunities to improve the people's experiences with cancer treatment and to improve care delivery. This is a single-arm, prospective, unblinded pilot study designed to evaluate the feasibility and acceptability of wearable sensor-based monitoring and incorporating electronic patient-reported outcomes (ePROs) in Phase I oncology clinical trials. The study will enroll participants enrolled in early phase clinical trials at the Cleveland Clinic Novel Therapeutics Clinic and aims to establish the foundation for future, larger-scale prospective studies integrating digital health technologies into early-phase cancer clinical trials. Participants will be offered a smartwatch device compatible to their phone's operating system and be guided through the installation and use of the researchers' free study mobile application. Participants already owning compatible smartwatch devices may elect to use their own smartwatch for the study.
Interventions
- DEVICE Wearable actigraphy
- OTHER Electronic Patient-Reported Outcomes (ePROs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07541365
The ClinicalTrials.gov registry entry for NCT07541365 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wearable actigraphy is the first listed.
NCT07541365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07541365 about?
NCT07541365 is a clinical study titled "Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials". Wearable sensors offer opportunities to improve the people's experiences with cancer treatment and to improve care delivery. This is a single-arm, prospective, unblinded pilot study designed to evaluate the feasibility and acceptability of wearable sensor-based monitoring and incorporating electroni...
What is the current status of trial NCT07541365?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07541365?
The interventions under investigation include: Wearable actigraphy (DEVICE), Electronic Patient-Reported Outcomes (ePROs) (OTHER).
Who is sponsoring clinical trial NCT07541365?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.